Google, Facebook and Amazon will all be focuses of antitrust cases in the year ahead, but a Trump administration will take a different approach to antitrust enforcement than Biden’s has.

Albertsons is giving up on its merger with Kroger and it is suing the grocery chain, saying it didn’t do enough to secure regulatory approval for the $24.6 billion agreement.

But would a new FTC chair under President-elect Donald Trump take a different view of the merger between the two grocery store companies?

Some companies with ongoing legal and regulatory disputes with federal agencies have an incentive to wait for the new, likely more business-friendly, administration to come into power.

In this week’s newsletter, we’re looking at how states are reviving lawsuits to block mail-order abortion pills, the FTC’s new rule that promised to curtail fake consumer reviews, and we do the numbers on down payment assistance programs.

Firms that sell subscriptions can count on significant revenue boosts from consumer spaciness. It helps if customers have to jump through hoops once they realize they’re shelling out for a product they don’t need. 

The Federal Trade Commission just announced that the agency would investigate whether companies are inflating grocery prices.

The Federal Trade Commission wants to know how firms are using surveillance pricing as ever more data on consumers is collected.

The Federal Trade Commission says companies like CVS Caremark, Express Scripts and OptumRx are artificially driving up prices for medications.

With pharmaceutical mergers more common, the FTC is taking a hard look at pharmacy benefit managers and antitrust concerns.